New Market Research Report: United Arab Emirates Pharmaceuticals & Healthcare Report Q4 2015

We uphold our outlook for continued strong growth in the UAE's pharmaceutical and healthcare markets, driven by expanding insurance coverage and medical tourism. Our growth outlook is supported by positive financial results for pharmaceutical distributor Al Ittihad Drug Store, and healthcare providers Al Noor Hospitals and NMC Health, with these results a good indicator of market growth. These key factors, boosted by strong economic performance and a relatively stable political environment make the UAE one of the most attractive markets for multinational drugmakers looking to set up operations in the Middle East.

Headline Expenditure Projections

Pharmaceuticals: AED9.46bn (USD2.58bn) in 2014 to AED10.29bn (USD2.80bn) in 2015; +8.7% in local currency terms and +8.8% US dollar terms. Forecast revised upwards form last quarter.
Healthcare: AED50.79bn (USD13.83bn) in 2014 to AED54.29bn (USD14.79bn) in 2015; +6.9% in local currency terms and +7.0% US dollar terms. Forecast revised upwards from last quarter.

Full Report Details at
- http://www.fastmr.com/prod/1052887_united_arab_emirates.aspx?afid=301

Risk/Reward Index

The UAE is one of the most rewarding markets for pharmaceutical and healthcare providers in the Middle East and African region. It has a fast-growing private healthcare sector, which brings with it demand for innovative and patented drugs. The UAE's relative political stability also contributes to the country's high regional score. In our Q3 2015 Indices, the UAE scores 59.4 and is the most attractive market in our Middle East and African regional matrix followed closely by Saudi Arabia (59.3).

The United Arab Emirates Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's United Arab Emirates Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the United Arab Emirates pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for United Arab Emirates, to test other views - a key input for successful budgeting and strategic business planning in the Emirati pharmaceutical and healthcare market.
* Target business opportunities and risks in the Emirati pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in United Arab Emirates.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- United States Pharmaceuticals & Healthcare Report Q4 2015
- United Kingdom Pharmaceuticals & Healthcare Report Q4 2015
- Ukraine Pharmaceuticals & Healthcare Report Q4 2015
- Puerto Rico Pharmaceuticals & Healthcare Report Q4 2015
- Jordan Pharmaceuticals & Healthcare Report Q4 2015